Daiichi Sankyo Europe has revealed the results of a Phase III study assessing the efficacy, safety, and tolerability of bempedoic acid/ezetimibe fixed-dose combination (FDC) tablet. / read more /
Cannuba has announced its support of the first national pilot study in the United Kingdom, Project TWENTY21, aimed at assessing prescription medical cannabis. / read more /
CHMP and CMDh have recommended that all marketing authorization holders (MAHs) of medicines containing liposomal drug delivery systems change the medicine name to avoid medication errors. / read more /
Orion Corporation has received FDA approval for darolutamide, a new treatment for men with non-metastatic castration-resistant prostate cancer (nmCRPC). / read more /
Iontas and Teva Pharmaceuticals have entered into an agreement for the application of technologies and know-how into the optimization of human antibodies to be used as biotherapeutics. / read more /
Cambrex has revealed that it is expanding its solid form screening and crystallization process development facility in Edinburgh, Scotland. / read more /
Pharmaceutical Technology Europe celebrates 30 years in publishing the latest insights, analysis, and developments of the bio/pharma industry. / read more /
European Union regulators have taken a significant step towards resolving some of the major supply-chain difficulties behind medicine shortages. / read more /
Rapid change towards industry developing and manufacturing niche APIs is leading to smaller-scale facilities that offer higher containment and flexibility. / read more /
The editors explore novel technologies for the formulation, manufacture,
purification, and delivery of sterile small- and large-molecule drugs including single-use systems, facilities and equipment, contamination issues, and process analytics.
